List of angiotensin converting enzyme inhibitors (ACEIs), with the U.S. Food and Drug Administration (FDA) approval status and examples of significant warnings.
In addition to the above, there are some less commonly used ACEi that are listed here with their dose equivalence.
Exclude ACEI drug X vs. ARB drug Y (e.g, enalapril manidipine vs. irbesartan HCTZ) - Exclude if ACEI, ARB, or direct renin inhibitor not on above list.
The WHO Essential Medicines List (EML) identifies all classes of antihypertensive drugs – angiotensin- converting enzyme inhibitors (ACEi), calcium channel
ACEI/ARB/DRI Scan Summary - Class Update: ACEIs, ARBs, DRIs Non-preferred drugs listed as N but without clinical drug use criteria are
In addition to the above, there are some less commonly used ACEi that are listed here with their dose equivalence.
In addition to the above, there are some less commonly used ACEi that are listed here with their dose equivalence.
Exclude ACEI drug X vs. ARB drug Y (e.g, enalapril manidipine vs. irbesartan HCTZ) - Exclude if ACEI, ARB, or direct renin inhibitor not on above list.
In addition to the above, there are some less commonly used ACEi that are listed here with their dose equivalence.
Comments